Managed Healthcare Executive’s Post

Check out our latest newsletter below + subscribe for quarterly updates related to pandemic preparedness and the 100DM ⬇

🚀 Delve into the #100DaysMission latest implementation report, a collective effort reflecting partner progress, current challenges, and future opportunities to implement this crucial mission. As we navigate the aftermath of COVID-19, the report outlines actions for all sectors to enhance preparedness, including renewed focus in 2024 on diagnostics, therapeutics, regulatory harmonisation and sustainable clinical trials. Explore the insights here: https://lnkd.in/e5q2SjTA

Developing digital therapeutics is hard and takes time. Listen in to hear about actual timelines of development and pitfalls to look out for. - With Jonas Albert Listen to the full episode here: https://lnkd.in/gEd3ndpH #DTx #DiGA #DiPA #digitalhealth #lifesciences

Digital therapeutics: value, evidence, and access in the Asia-Pacific region https://lnkd.in/gxufRWnU In this article, we explore the current developments and trends in access for digital therapeutics in the Asia-Pacific region, including the role of superapps in navigating the diverse regulatory and reimbursement landscapes. https://lnkd.in/gxufRWnU #HEOR #MarketAccess #WeAreAvalereHealth

What Are @Digital Therapeutics? Here is an article with the list of Top 10 Companies in #digitaltherapeutics in 2024. Read here: https://lnkd.in/dYTdMti4

Qatar Investment Authority (QIA) dedicated to healthtech by investing in innovative healthcare companies as well as funds Latest investment in startups: 🇺🇸 Outpace Bio (Aug 2024, Series B, $144 million, CEO Marc Lajoie) is a cell therapy company using unrivaled AI-powered protein design to program immune cells for improved function inside patients battling solid tumors 🇺🇸 Iambic Therapeutics (Jun 2024, Series B+, $50 million, CEO Thomas Miller) is a clinical-stage biotechnology company developing novel therapeutics using its unique AI-driven discovery platform 🇬🇧 Autolus Therapeutics (Feb 2024, equity investment, $250 million + $350 million, CEO Christian Itin) is a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies 🇮🇳 Global Dental Services (Nov 2023, equity investment, $50 million, CEO Amarinder Singh) India's largest tech-enabled-dental-platform that operates more than 400 company-owned and company-operated dental clinics under the “Clove Dental" banner 🇺🇸 BridgeBio (Sep 2023, PIPE financing, $250 million, CEO Neil Kumar) is a commercial-stage biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers 🇺🇸 Star Therapeutics (Sep 2023, Series C, $90 million, CEO Adam Rosenthal) is a biotechnology company with a mission to develop life-changing therapies for as many rare diseases as possible for the millions of patients in urgent need Contact QIA Healthcare Investment Team https://lnkd.in/ezbyKmtM Investment in funds: 🇶🇦🤝🇫🇷 Future French Champions (May 2024, €300 million) is a joint-venture between Qatar Investment Authority (QIA) and Bpifrance that has invested almost €600 million over two phases to boost economic growth and innovation in France. As the 3rd phase, they have announced intention to increase their commitment by up to another €300 million once the current commitment is fully deployed.  The strategic priorities:  🤖 Artificial Intelligence (AI) 🏿 Semiconductors ⚛️ Quantum Computing 🏥 Healthcare 🚀 Aerospace ⚡ Energy Transition This year, QIA also announced (https://lnkd.in/eARVkTBT) the creation of a $1 billion VC fund of funds to support the development of the local entrepreneurial ecosystem. The sectors of interest: 🖥 Technology 🏥 Healthcare 💳 Fintech 🎓 Edtech Contact QIA Funds Investment Team https://lnkd.in/eRVD5r7k 

Let us help you with your therapeutics discovery and development challenges. Please download this short slide deck that summarizes our capabilities and then book a call with us at the following link if you would like to learn more. https://lnkd.in/gdGx_AKj

I see plenty of life science organisations implement new equipment and technology to improve operations but fail to appreciate the significant impact on productivity and cost reductions from adopting the principles of #operationalexcellence . Continuous improvement should be part of an organiations culture and way of working, not just as a one-off exercise.

Ever heard of digital therapeutics? What are they in the first place? - With Jonas Albert Listen to the full episode here: https://lnkd.in/gEd3ndpH #DTx #DiGA #DiPA #digitalhealth #lifesciences

New article published in Drug Discovery Today: Making Good Decisions in Early Drug Discovery Our team is excited to share a new article co-authored by Martin Stahl (LifeMine Therapeutics), Virginie Sandrin (Roche), and Bigna Wörsdörfer (Roche) with Ellen Coopersmith and Samuel Vardy of Decision Frameworks.  The article shares a proven and effective Decision Quality approach that guides collaborative team discussions to generate alternative discovery advancement plans and qualitatively assess them. The product is a clear decision roadmap for the team to follow and readjust as research progresses.  Read the full article here: https://lnkd.in/g_-h2gRq     #DecisionMaking #DecisionQuality #DrugDiscovery #Strategy #Uncertainty